CTOs on the Move

VGM Group

www.vgmgroup.com

 
Headquartered in Waterloo, Iowa, VGM is a 100 percent employee-owned company providing business and professional services to thousands of business customers across North America. Services include group purchasing, commercial insurance, management of healthcare services and networks in post-acute cases, healthcare distribution direct to patient homes, specialty consulting, on-line education, digital, print and traditional marketing and more. VGM employs more than 1000 people across 30 states and Canada. Approximately 875 people work in the Waterloo offices and the remainder work in one of VGM`s eight offices outside of Waterloo or work from home. VGM has been named the Top Workplace in ...
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.vgmgroup.com
  • 1111 West San Marnan Drive D4
    Waterloo, IA USA 50701
  • Phone: 888.828.5928

Executives

Name Title Contact Details
Bryan Tonne
VP-IT Operations Profile
Ryan Wood
Chief Information Security Officer Profile

Similar Companies

Affinity Benefit Services

Affinity Benefit Services is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alive Hospice Of Nashville

Alive Hospice has been offering loving care to people with life-threatening illnesses, support to their families and service to the community in a spirit of enriching lives since 1975. As the oldest community-based hospice in Middle Tennessee, we

Body By Design CHS

Body By Design Charleston is a locally owned and operated med spa that offers body sculpting treatments using UltraShape and VelaShape III. They also offer facial rejuvenation treatments and sell skincare products.

Ellie Diagnostics

Ellie Diagnostics was founded to offer vets a simpler way to diagnose and treat animals with confidence, while helping animals live longer, healthier lives.

Alector

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.